임상교실 - 교수진 소개

김열홍 교수

김열홍 교수

김열홍 / Yeul-Hong Kim

  • 소속내과학교실
  • 직위주임교수
  • 세부전공혈액종양내과
  • 연구실위치
  • 구내전화번호안5569
  • 팩스
  • 이메일yhk0215@korea.ac.kr
학력사항
. 고려대 의학 학사
. 고려대 의학 석사
. 고려대 내과학 박사
. M.D. Anderson Cancer Center Gastrointestinal Medical Oncology Postdoctoral fellow
. M.D. Anderson Cancer Center Thoracic Medical Oncology Postdoctoral fellow
교육 및 경력사항
2001~2002 혈액종양내과 임상과장(분과장)
2012 혈액종양내과 암센터장
2001~2011 보건복지부지정 폐암, 유방암/난소암 유전체연구센터 소장
2007 보건의료심사평가원 암질환심의위원회
2002 M.D. Anderson Cancer Center visiting scientist
학술활동
2004 대한암학회 상임이사, 총무이사, 편집부위원장
2005~2008 한국임상암학회 총무이사
2007~2010 대한내과학회 수련이사
2007~2012 대한항암요법연구회 총무, 위암분과위원장, 회장
2008 한국유전체학회 운영위원장, 부회장, 차기 회장
대표논문
  • Primary Adrenal Lymphoma Presenting with Cauda Equina Syndrome/200811

  • Single nucleotide polymorphisms of IGFBP-3 gene and lung cancer risk in a Korean population/200811

  • The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-kappa B activity and down-regulating Bfl-1/201108

  • Capecitabine monotherapy as salvage treatment after failure of chemotherapy containing oxaliplatin and irinotecan in patients with metastatic colorectal cancer/201103

  • Epidermal Growth Factor Receptor Mutations as a Prognostic Factor in Korean Patients with Advanced Lung Adenocarcinoma Who Had Not Been Treated with Received Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors/201101

  • Mitomycin-C, 5-fluorouracil, and leucovorin as a salvage therapy in patients with metastatic colorectal adenocarcinoma/201012

  • Selection of a Patient Subgroup with Advanced Esophageal Squamous Carcinoma Who Could Benefit from Second-Line Chemotherapy/201012

  • Prognostic Significance of Serum Vascular Endothelial Growth Factor Per Platelet Count in Unresectable Advanced Gastric Cancer Patients/201012

  • Methylation of AKAP12 alpha Promoter in Lung Cancer/201011

  • A phase I/II and pharmacogenomic study of pemetrexed and cisplatin in patients with unresectable, advanced gastric carcinoma/201009

  • Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma in Korea/201009

  • A Study of RET Proto-oncogene Polymorphisms in Association with Lung Cancer Risk in the Korean Population/201009

  • High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer/201008

  • The 5p15.33 Locus Is Associated with Risk of Lung Adenocarcinoma in Never-Smoking Females in Asia/201008

  • Individualized Tumor Response Testing for Prediction of Response to Paclitaxel and Cisplatin Chemotherapy in Patients with Advanced Gastric Cancer/201005

  • Genomic alterations of chromosome region 11p as predictive marker by array comparative genomic hybridization in lung adenocarcinoma patients/201004

  • Genomic alterations of chromosome region 11p as predictive marker by array comparative genomic hybridization in lung adenocarcinoma patients/201004

  • Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial/201003

  • The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic disease/201003

  • A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer/201002

  • Association of a progesterone receptor gene+331 G/A polymorphism with breast cancer risk: a meta-analysis/201001

  • Association of a progesterone receptor gene+331 G/A polymorphism with breast cancer risk: a meta-analysis/201001

  • Chemotherapy Related Oral and Gastrointestinal Mucositis/200909

  • DNA profiling by array comparative genomic hybridization (CGH) of peripheral blood mononuclear cells (PBMC) and tumor tissue cell in non-small cell lung cancer (NSCLC)/200909

  • Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study/200907

  • Single-nucleotide polymorphisms in the promoter of the CDK5 gene and lung cancer risk in a Korean population/200905

  • Array CGH Reveals Genomic Aberrations in Human Emphysema/200905

  • Microtubule-damaging Agents Enhance RASSF1A-induced Cell Death in Lung Cancer Cell Lines/200903

  • Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis/200902

  • Phase I dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer/200901

  • The genetic polymorphisms of HER-2 and the risk of lung cancer in a Korean population/200812

  • Effect of BRCA1 Haplotype on Survival of Non-Small-Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy/200812

  • Varicella Zoster Virus Infection during Chemotherapy in Solid Cancer Patients/201201

  • Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer/201110

  • A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer/200810

  • Putative association of the single nucleotide polymorphisms in RASSF1A promoter with Korean lung cancer/200809

  • Extrinsic nitric oxide donor partially reverses arginine deiminase induced cell growth inhibition through NF kappa B and Bcl-X-L/200806

  • PPAR-gamma ligand promotes the growth of APC-mutated HT-29 human colon cancer cells in vitro and in vivo/200806

  • Association study of TP53 polymorphisms with lung cancer in a Korean population/200806

  • Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study/200806

  • The functional implications of Akt activity and TGF-beta signaling in tamoxifen-resistant breast cancer/200803

  • Properties of the amniotic membrane may be applicable in cancer therapy/200802

  • Reduced dose of imatinib for patients with chronic myeloid leukemia and low body surface area/200711

  • Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue/200711

  • Combinational treatment with retinoic acid derivatives in non-small cell lung carcinoma in vitro/200709

  • Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea-Japan collaborative study group trial/200707

  • Lack of association of fragile histidine triad (FHIT) polymorphisms with lung cancer in the Korean population/200707

  • A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer/200705

  • Telomere length shortening of peripheral blood mononuclear cells in solid-cancer patients undergoing standard-dose chemotherapy might be correlated with good treatment response and neutropenia severity/200704

  • Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer/200702

  • Epirubicin, cisplatin, oral UFT, and leucovorin combination chemotherapy in advanced and metastatic esophageal cancer/200701

  • Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung/200701

  • Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial/201201

  • A Prognostic Model to Identify Patients with Advanced Pancreas Adenocarcinoma Who Could Benefit from Second-line Chemotherapy/201203

  • The 18p11.22 locus is associated with never smoker non-small cell lung cancer susceptibility in Korean populations/201203

  • Elevated fibroblast growth factor-inducible 14 expression promotes gastric cancer growth via nuclear factor-kappa B and is associated with poor patient outcome/201201
  • 목록